Resmed currently trades with a PEG ratio of 2.3, based on Aug 21, 2026 data. Dividing the 22.11 PE ratio by the 9.6% earnings growth rate produces this figure. Relative to the 1.35 average from the past 4 quarters, the PEG ratio has surged by 70%.
Historically, Resmed maintains a PEG ratio averaging 5.16 across the last nine years. At 2.3, today's PEG ratio sits 55% lower than its historical average. The nine years high came in the Dec 2019 quarter at 81.48, reflecting peak valuation relative to growth. The bottom was reached in the Sep 2020 quarter at 0.6, suggesting favorable value relative to growth during that period.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2026 | 1.94 | 18.61 | 9.6% |
| 2025 | 0.72 | 27.02 | 37.6% |
| 2024 | 2.06 | 27.58 | 13.4% |
| 2023 | 2.45 | 35.7 | 14.6% |
| 2022 | 0.62 | 39.26 | 63.3% |
| 2021 | N/A | 75.39 | -24.1% |
| 2020 | 0.85 | 44.55 | 52.3% |
| 2019 | 1.53 | 43.12 | 28.1% |
| 2018 | N/A | 46.87 | -8.7% |
| 2017 | N/A | 32.18 | -3.6% |
| 2016 | N/A | 25.19 | 0% |
| 2015 | 7.74 | 22.46 | 2.9% |
| 2014 | 1.54 | 20.75 | 13.5% |
| 2013 | 0.92 | 20.99 | 22.9% |
| 2012 | 1.02 | 17.83 | 17.4% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 1.94 | 18.61 | 9.6% |
| Mar 2026 | 1.32 | 21.58 | 16.3% |
| Dec 2025 | 1.21 | 23.73 | 19.6% |
| Sep 2025 | 0.94 | 27.9 | 29.8% |
| Jun 2025 | 0.72 | 27.02 | 37.6% |
| Mar 2025 | 0.67 | 25.04 | 37.1% |
| Dec 2024 | 0.67 | 26.94 | 40.1% |
| Sep 2024 | 1.44 | 32.29 | 22.5% |
| Jun 2024 | 2.06 | 27.58 | 13.4% |
| Mar 2024 | 2.84 | 30.37 | 10.7% |
| Dec 2023 | 2.96 | 28.39 | 9.6% |
| Sep 2023 | 1.63 | 23.97 | 14.7% |
| Jun 2023 | 2.45 | 35.7 | 14.6% |
| Mar 2023 | 3.68 | 37.18 | 10.1% |
| Dec 2022 | 0.7 | 37.64 | 54% |
RMD's PEG ratio today is above the 3 and 5-year averages, yet it comes in under the 10-year average.
With a PEG of 2.3, RMD ranks higher than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 0.61, Resmed's PEG is 277% higher.
Among its peers, RMD has a PEG ratio below stocks TMO and MDT, while higher than ELMD's.
Based on Aug 21, 2026 data, RMD shows a PEG ratio of 2.3.
RMD shows a 3-year average PEG ratio of 1.53.
RMD shows a 5-year average PEG ratio of 1.51.
The Dec 2019 quarter marked the nine years high at 81.48 for RMD's PEG ratio.
Compared to the 9-year average, RMD's PEG ratio sits 55% lower.
When a company's earnings growth lags its valuation, the PEG ratio tends to be elevated - as seen with RMD's 2.3 reading.
Computing the PEG ratio involves dividing the PE ratio by the company's EPS growth rate (YoY TTM). As of Aug 21, 2026, Resmed carries a PE ratio of 22.11. Earnings grew at 9.6% over the TTM period ending Jun 2026. Applying the formula, this yields a PEG ratio of 2.3. PEG RATIO(2.3) = PE RATIO(22.11) / EPS GROWTH(9.6%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.